GRANT ANNOUNCEMENTS
Innovative/Translational Caner Research - Mary Kay Ash Charitable Foundation
Application Receipt Date: February 15, 2005
Mary Kay Ash Charitable Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research in ovarian, uterine, breast, or cervical cancer. Only one grant application will be accepted from each accredited school. The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period. If indirect costs are requested, they cannot exceed 15%. If selected, the funds will be paid in two payments. Complete application may be requested from Roxy McCann
doni0007@umn.edu or 5-2662.
Translational Research Program 2005 - Leukemia – Lymphoma – Myeloma
Application Receipt Date: March 15, 2005
The Leukemia & Lymphoma Society provides early-stage support for clinical research on leukemia, lymphoma and myeloma, which is intended to develop innovative approaches to treatment, diagnosis or prevention. The program fosters collaboration between basic research findings to clinical usefulness. The Translational Research Program is specifically intended for the support of work that has clinical application as a near-term goal. Proposal should be based on epidemiological, molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the clinical exploitation of the studies proposed. The feature of the proposal will be an important consideration of the review process. Awards will be limited to a maximum of $200,000, which include direct costs and a maximum overhead of $20,000 or 11.1% of the direct costs per year for three years. Renewal funding for two additional years may be available from the Society.
http://www.LLS.org
Pre-Application Meeting for NCI Alliance for Nanotechnology in Cancer
The Office of Technology and Industrial Relations, Office of the Director, National Cancer Institute, will hold a pre-application meeting for investigators planning to submit applications in response to Request for Applications (RFA) to be released under the NCI Alliance for Nanotechnology in Cancer, including RFA CA-05-024 "Centers of Cancer Nanotechnology Excellence" (U54) (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-024.html) and RFA CA-05-026 "Cancer Nanotechnology Platform Partnerships" (R01) (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-026.html). This meeting will provide prospective applicants with an opportunity in a public meeting to receive answers to their questions about the RFA. Representatives from the following offices will be available to answer questions relevant to applications responding to these RFAs: Office of Technology and Industrial Relations (OTIR), NCI; Division of Cancer Biology, NCI; Grants Administration Branch, NCI; and the Special Review and Resources Branch, NCI. Staff will be available to discuss the intent and requirements of the RFA. The complete text of these RFAs will be available via this website as soon as they are posted on the NIH Guide. Potential applicants to these RFAs are not required to attend the pre-application meeting.
http://grants.nih.gov/grants/guide/notice-files/NOT-CA-05-006.html http://grants.nih.gov/grants/guide/notice-files/NOT-CA-05-006.html
Centers of Cancer Nanotechnology Excellence
Letters-Of-Intent Receipt Date: February 25, 2005
Application Receipt Date: March 25, 2005
The NCI invites applications from investigators interested in participating in an initiative to establish up to five Centers for Cancer Nanotechnology Excellence (CCNEs). The CCNEs will be a national resource that will integrate the basic and clinical sciences with engineering to develop and apply nanotechnology to cancer research to accelerate the application of this science to the clinic. Using the NIH U54 cooperative agreement mechanism, the NCI intends to commit approximately $90.8 M in FY 2005-2009 (approximately $20 M in FY 2005) to fund up to five CCNEs. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with his or her institution to develop an application for support. An individual can be the PI on only one application submitted under this announcement. However, an individual may be listed as a participant in multiple CCNE applications provided that his/her research proposals are discrete. Application materials are available from the NIH Office of Extramural Research (OER); http://grants.nih.gov/grants/oer.htm/
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-025.html
Cancer Nanotechnology Platform Partnerships
Letter of Intent Receipt Date: February 25, 2005
Application Receipt Date: March 25, 2005
The National Cancer Institute (NCI) invites applications for research project grants (RPGs) to support development of nanotechnology platforms for basic, applied, and translational multi-disciplinary research that uses nanotechnology (e.g., nanoscale devices or nanomaterials less than 1000 nm in size, although the assembly, synthesis, and/or fabrication of components at dimensions less than 300 nm should be demonstrated ) in cancer research. Proposed projects will be eligible for consideration if they address one or more of the following thematic/programmatic areas of focus: molecular imaging and early detection, in vivo imaging, reporters of therapeutic efficacy, multifunctional therapeutics, prevention and control of cancer, and research enablers. This funding opportunity will use the R01 award mechanism. The NCI intends to commit approximately 7 million dollars in FY 2005 to fund approximately 10 new grants in response to this RFA. An applicant may request a project period of up to 5 years and a budget for total costs up to 1 million dollars per year. An applicant may submit one application in response to this RFA. Application materials are available from the NIH Office of Extramural Research (OER); http://grants.nih.gov/grants/oer.htm .
http://grants.nih.gov/grants/guide/notice-files/NOT-CA-05-006.html
Community Participation in Research
Letters of Intent Receipt Date (s): April 17, 2005, 2006, 2007
Application Receipt Dates(s): May 17, 2005, 2006, 2007
The ultimate goal of this PAR is to support research on health promotion, disease prevention, and health disparities that is jointly conducted by communities and researchers. This PAR invites NIH research project grant (R01) and exploratory/developmental grant (R21) award mechanisms. The number of applications each applicant may submit is unrestricted. http://grants.nih.gov/grants/guide/pa-files/PAR-05-026.html
To view all grants available through the Cancer Center, visit http://www.cancer.umn.edu/page/aboutus/grantopp.html